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Abstract
Purpose: Less than 10% of heart failure patients in the UK participate in cardiac rehabilitation programmes. The
present pilot study evaluated feasibility, acceptability and physiological effects of a novel, personalised, home-based
physical activity intervention in chronic heart failure.
Methods: Twenty patients (68 ± 7 years old, 20% females) with stable chronic heart failure due to reduced left
ventricular ejection fraction (31 ± 8 %) participated in a single-group, pilot study assessing the feasibility and
acceptability of a 12-week personalised home-based physical activity intervention aiming to increase daily number
of steps by 2000 from baseline (Active-at-Home-HF). Patients completed cardiopulmonary exercise testing with
non-invasive gas exchange and haemodynamic measurements and quality of life questionnaire pre- and post-
intervention. Patients were supported weekly via telephone and average weekly step count data collected using
pedometers.
Results: Forty-three patients were screened and 20 recruited into the study. Seventeen patients (85%) completed
the intervention, and 15 (75%) achieved the target step count. Average step count per day increased significantly
from baseline to 3 weeks by 2546 (5108 ± 3064 to 7654 ± 3849, P = 0.03, n = 17) and was maintained until week
12 (9022 ± 3942). Following completion of the intervention, no adverse events were recorded and quality of life
improved by 4 points (26 ± 18 vs. 22 ± 19). Peak exercise stroke volume increased by 19% (127 ± 34 vs. 151 ± 34
m/beat, P = 0.05), while cardiac index increased by 12% (6.8 ± 1.5 vs. 7.6 ± 2.0 L/min/m2, P = 0.19). Workload and
oxygen consumption at anaerobic threshold also increased by 16% (49 ± 16 vs. 59 ± 14 watts, P = 0.01) and 10%
(11.5 ± 2.9 vs. 12.8 ± 2.2 ml/kg/min, P = 0.39).
Conclusion: The Active-at-Home-HF intervention is feasible, acceptable and effective for increasing physical activity
in CHF. It may lead to improvements in quality of life, exercise tolerance and haemodynamic function.
Trial Registration: www.clinicaltrials.gov NCT0367727. Retrospectively registered on 17 September 2018.
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Key Points
 A personalized, home-based physical activity inter-
vention is acceptable and feasible and could lead to
improvement in exercise tolerance and quality of life
in chronic heart failure patients.
 Increasing step count by at least 2000 steps per day
may be a realistic goal for chronic heart failure
patients.
Background
The benefits of cardiac rehabilitation in chronic heart
failure (CHF) have been well documented [1]. Evidence-
based clinical guidelines recommend that physical activ-
ity is integrated into cardiac rehabilitation as a corner-
stone of clinical management of CHF [2]. Meta-analyses
have demonstrated that increased physical activity can
improve functional capacity and quality of life, can re-
duce symptom burden and likelihood of hospitalisation
and can improve cardiac function [3, 4]. Consequently,
current guidelines now emphasize physical activity as an
important component of cardiac rehabilitation in
addition to patient education, psychological support and
drug therapy [2, 5, 6].
Despite numerous benefits, participation of heart fail-
ure patients in cardiac rehabilitation is low. In the
United Kingdom (UK), less than 10% of patients with
CHF participate in cardiac rehabilitation [7]. Potential
explanations include exclusion of cardiac rehabilitation
programmes from local commissioning agreements due
to limited funds, lack of capacity for supervised pro-
grammes and inadequate social support for patients [8].
Other patient factors include unwillingness to participate
in cardiac rehabilitation due to difficulties in attending
hospitals, work or domestic commitments and reluc-
tance to attend group-based classes [9].
The barriers highlighted above could be potentially
overcome by promoting increased physical activity at
home. Daily habitual physical activity (i.e. number of
steps and active energy expenditure) is inversely related
to patients’ symptoms [10]. Walking is an independent
predictor of outcomes in patients with advanced CHF
[11]. Current physical activity recommendations for
adults are 150 to 300 min per week of moderate-
intensity activity, or 75 to 150 min per week of vigorous-
intensity aerobic physical activity, or an equivalent com-
bination of moderate- and vigorous-intensity aerobic ac-
tivity while incorporating muscle-strengthening activities
if tolerated [6]. For adults who are unable to meet these
guidelines due to chronic conditions or disabilities, regu-
lar physical activity according to their ability is recom-
mended [6]. As such, it may be challenging to identify a
standardised daily physical activity routine appropriate
for all heart failure patients’ accounting for individual
differences. Pedometer-based interventions have demon-
strated that increasing steps per day by approximately
2000–2500 steps leads to improvements in blood pres-
sure [12, 13] and insulin sensitivity [14]. Furthermore, a
large cohort study involving 9306 participants reported a
10% risk reduction of cardiovascular events in individ-
uals at high risk of developing type 2 diabetes for every
2000 steps per day increment in daily physical activity
observed [15]. Considering these findings, we developed
a novel, personalised, home-based (Active-at-Home-HF)
physical activity intervention aiming to increase daily
physical activity by 2000 steps in patients with CHF. The
aim of the present pilot study was to assess feasibility,
acceptability and preliminary efficacy of the Active-at-
Home-HF intervention.
Methods
Study Design
A single-group, pilot study assessed the feasibility, ac-
ceptability and preliminary efficacy of a home-based
physical activity intervention in adults with CHF with re-
duced left ventricular ejection fraction. Eligible partici-
pants attended the Clinical Research Facility of the Royal
Victoria Infirmary, Newcastle upon Tyne, UK, for two
separate visits (i.e. before and after the 12-week inter-
vention). Participants were contacted via email, tele-
phone or spoken to in person to discuss the study and
given an opportunity to ask questions to ensure they
understood the procedure.
Participants
Potentially eligible patients were identified by cardiolo-
gists via medical records from heart failure clinics at the
Royal Victoria Infirmary and Freeman Hospital in New-
castle upon Tyne. These patients were subsequently
screened by the same cardiologists using the study eligi-
bility criteria. Once eligibility was confirmed, patients
were recruited by a member of the research team (NO,
SC) by telephone contact. The study included patients
with a left ventricular ejection fraction ≤ 40%, diagnosed
for at least 3 months, classified according to the New
York Heart Association (NYHA) class II–III, clinically
stable and receiving an optimal medical treatment. Pa-
tients were required to have no contraindications to
physical activity and had to be capable of performing ac-
tivities of daily living independently. Patients were ex-
cluded during screening or contact if they had
uncontrolled cardiac arrhythmias, myocardial infarction,
percutaneous coronary intervention and/or bypass graft
surgery up to 3months previously, severe obesity (i.e.
body mass index > 40) and implantation with left ven-
tricular assist device; were currently participating in a
cardiac rehabilitation programme; if they already met
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physical activity recommendations [6]; or were unable to
provide informed written consent.
Clinical Assessments
During baseline and 12-week follow-up visits, patients
underwent clinical assessments including quality of life using
the Minnesota Living with Heart Failure questionnaire,
blood sampling for N-Terminal pro b-type Natriuretic Pep-
tide (NTproBNP) and cardiopulmonary pulmonary exercise
stress testing on a semi-recumbent cycle ergometer (Corival,
Lode & Groningen, Netherlands) coupled with non-invasive
haemodynamic monitoring (NICOM®, Cheetah Medical,
Delaware, USA). A graded exercise test protocol was used
for cardiopulmonary exercise testing. This involved main-
taining a pedal frequency of 60–70 revolutions per minute
with workload increasing at the rate of 10 W per minute.
The test was terminated when maximal exertion was
achieved, or when the patient was unable to maintain the re-
quired cycling cadence, or if the patient desired to stop.
Physical activity (step count) was measured continuously
using a pedometer (Omron Health care, Model no: HJ-321-
E, Japan). Patients recorded daily step counts at the end of
each day using a paper-based activity tracker, and results
were communicated weekly to a member of the study team.
The Home-Based Physical Activity Programme (Active-at-
Home-HF)
The Active-at-Home-HF intervention was designed
for patients with CHF to encourage an increase in
their overall daily physical activity levels by at least
2000 steps per day from baseline. This behavioural
intervention was delivered by telephone to participants
in the north-east of England who were patients at the
Royal Victoria Infirmary or Freeman Hospital, New-
castle upon Tyne. The intervention team comprised of
cardiologists, exercise physiologists and health psy-
chologists. Team members (NCO and SC) involved in
monitoring patients were experienced clinical exercise
physiologists certified by the American College of
Sports Medicine. They also received training delivered
by a chartered health psychologist with expertise in
health behaviour change (LA) who was also a member
of the research team, on the delivery/use of evidence-
based behaviour change techniques selected to target
physical activity behaviour (e.g., physical activity goal
setting, problem solving, self-monitoring) [16, 17].
The same health psychologist developed the brief be-
havioural intervention, intended for delivery by tele-
phone using a proforma to prompt use of the specific
behaviour change techniques. This proforma also
served as a record for future discussions following
completion during each intervention session delivered.
The intervention differed from centre-based pro-
grammes in that it focussed on free-living physical
activity, did not rely on exercise equipment, was deliv-
ered by weekly telephone sessions and focussed on
providing participants with the knowledge and behav-
ioural skills to increase and maintain physical activity
levels despite the barriers they might face. Once pa-
tients enrolled in to the study, they were supported by
weekly telephone calls lasting approximately 10 min in
duration, designed to initiate, increase and maintain
their activity levels. This was achieved through behav-
ioural goal setting where the patient would set a phys-
ical activity goal with the guidance and support of a
trained research team member. Barriers to reaching
the goal were discussed followed by mutual identifica-
tion of solutions to overcome those barriers. Patients
were encouraged to consider times in the past where
they had been more physically active as a means of in-
creasing confidence and motivation. Self-monitoring
was used to encourage maintenance of activity levels,
and patients were prompted to involve family mem-
bers and friends in their attempts to increase physical
activity levels as a means of social support. At the end
of each day, the goal was to achieve at least 2000 steps
more than the average daily number of steps obtained
at baseline as indicated on the pedometer. Physical ac-
tivity levels were adjusted on an individual basis as
conditioning took place, with the emphasis on volume
of activity, i.e. duration and number of steps rather
than intensity.
Outcomes
The primary outcomes of interest were acceptability and
feasibility of the intervention. Secondary outcomes were
changes in functional capacity assessed by peak exercise
oxygen consumption and power output, quality of life,
haemodynamic function and changes in NTproBNP.
Feasibility was defined as willingness of patients to enrol
on to the Active-at-Home-HF intervention and was con-
firmed by recruiting the targeted number of patients.
The recruitment target deadline was set at 9 months
after recruiting first patient. Acceptability was defined as
willingness to engage with and adhere to the interven-
tion and was reported as the percentage of patients who
completed intervention. The intervention was consid-
ered acceptable if ≥ 80% of patients completed it. This
included weekly engagement by telephone and comple-
tion of daily physical activity records. If engagement with
each of these components was recorded, the intervention
was considered acceptable.
Statistical Analysis
The primary aim of the present study was to assess accept-
ability and feasibility of the intervention. It is generally ac-
cepted that pilot feasibility studies do not require a formal
power calculation [18]. However, it was important to assess
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whether the Active-at-Home-HF intervention, if acceptable
and feasible, was capable of improving outcomes of interest
to allow a judgement to be made as to whether the inter-
vention is comparable to a centre-based intervention. It
was therefore estimated that a sample size of 20 patients
would provide sufficient power to detect a clinically accept-
able change/increase in peak oxygen consumption of 3ml/
min/kg post-intervention, at the significance level of 5% (β
= 0.82, α = 0.05). The relationship between physical activity
and physiological variables was assessed using Pearson’s co-
efficient of correlation. Statistical significance was indicated
if P < 0.05. All statistical analyses were carried out using
SPSS version 24.0 (SPSS, Chicago, IL, USA).
Results
Acceptability and Feasibility
Out of 43 CHF patients contacted by telephone after
initial screening, 20 patients met the study inclusion
criteria and were willing to take part and were subse-
quently recruited. Recruitment took place between
December 2015 and September 2016. Patients were
excluded (n = 23) if they already met recommended
physical activity guidelines [5] (n = 4), were too ill to
participate (NYHA stage IV) or were recently hospita-
lised (n = 8). Patients were also excluded if they re-
fused to participate for personal reasons (n = 4), time
commitment (n = 3), ‘feeling not be able to due to age’
(n = 1) or being too nervous to participate in a phys-
ical activity intervention (n = 3). Recruited patients’
demographic and clinical characteristics are presented
in Table 1. No adverse events occurred as a result of
participating in the intervention/study. Seventeen par-
ticipants completed the 12-week physical activity
intervention. However, two patients were unable to
meet or sustain the required minimum target of 2000
steps above baseline due to severe arthritis. The inter-
vention was considered acceptable and feasible as the
required number of patients were recruited, and the
majority of patients completed the intervention (com-
pletion rate 85%; n = 17) (see Fig. 1).
In situations where patients expressed concerns about
their arrhythmias or ischaemia, they were further
assessed by the team’s consultant cardiologist and were
reassured about safety of participation in the interven-
tion before they took part in the study.
The target step count goal of 2000 steps from baseline
was achieved at week three with average number of steps
per day increasing significantly by 2546 (from 5108 ±
3064 to 7654 ± 3849 steps/day, p = 0.03), and was main-
tained until week 12 (8890 ± 3713 steps/day, Fig. 2).
Two patients dropped out of the study for undisclosed
reasons, and one participant discontinued due to im-
plantable cardiac defibrillator malfunction.
Metabolic Changes
There was no statistically significant change in exercise tol-
erance with peak oxygen consumption and peak workload
increasing post-intervention by 4.8% and 11% respectively.
However, workload and oxygen consumption at submaxi-
mal exercise (i.e. anaerobic threshold) increased by 20% (49
± 16 vs. 59 ± 14 watts, P = 0.01) and 11% (11.5 ± 2.9 vs.
12.8 ± 2.2ml/kg/min, P = 0.39) post-intervention (Table 2).
Haemodynamic Changes
The completion of the intervention resulted in signifi-
cant improvements in peak exercise stroke volume
(126.5 ± 33.8 vs. 150.8 ± 33.5 ml/beat, P = 0.05) and
stroke volume index (64.6 ± 14 vs. 75.2 ± 17 ml/beat/m2,
P = 0.04). There was also a 10–15% improvement in
peak exercise cardiac output and cardiac index, although
these were not statistically significant (Table 2).
Blood Biomarkers and Quality of Life
There were no statistically significant changes in
metabolic biomarkers following completion of the
Table 1 Mean and SD (±) of patients’ demographic and clinical
characteristics
Parameter
Age (years) 68 ± 7
Men/women 18/2
Weight (kg) 84 ± 15
Height (cm) 1.72 ± 0.1
Aetiology of HF (IHD/DCM) 10/10
LVEF (%) 31 ± 8
Medication
ACE inhibitors 15
β-blockers 20
ARBs 5
Diuretics 13
Anti-arrhythmic 3
NSAIDs/pain killers 6
Warfarin 5
ICD/pacemakers 13
Comorbidities
COPD 1
Type 2 diabetes 5
Obesity 6
Hypertension 20
Depression 2
Arthritis 1
ACE angiotensin converting enzyme, ARB angiotensin receptor blockers, LVEF
left ventricular ejection fraction, NSAID non-steroid anti-inflammatory drugs,
IHD, ischaemic heart disease, DCM dilated cardiomyopathy, COPD chronic
obstructive pulmonary disease, ICD implantable cardioverter defibrillator
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intervention. There was a 4-point improvement in
quality of life score (Table 3).
Daily number of steps correlated positively with
peak oxygen consumption post-intervention (r = 0.58,
P = 0.01), but not pre-intervention (r = 0.39, P = 0.08).
The significant correlation observed post-intervention,
although moderate, suggests that daily physical activity
is positively associated with functional capacity (exer-
cise tolerance) in active but not sedentary patients
with chronic HF (Fig. 3). This suggests that increasing
daily walking improves fitness levels in heart failure
patients.
Discussion
The major findings of this study are that the Active-at-
Home-HF intervention demonstrated to be both accept-
able and feasible to patients with CHF and led to modest
changes in exercise tolerance and haemodynamics. This
was shown by the number of patients (85%) who engaged
with and completed the intervention after enrolment. This
figure is comparable to adherence rates (> 75%) reported
from centre-based studies [19, 20]. Piotrowicz et al. [20],
who compared a home-based tele-monitored cardiac re-
habilitation to centre-based rehabilitation, reported 100%
adherence in the home-based group. Seventy-five percent
Fig. 1 Flow diagram showing patient screening and recruitment into Active-at-home HF intervention
Fig. 2 Mean (+ SD) number of steps achieved at baseline and at the end of weeks 3 and 12 of physical activity intervention
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of dropouts in the centre-based group of the above study
were due to inadequate funds and availability of transport
while 25% dropped out due to difficulty in matching the
centre-based training with their daily activities. These
findings are important because the intervention has shown
to provide a viable and potentially low-cost (i.e. brief be-
havioural intervention delivered by telephone, no reliance
on exercise equipment provision in clinical settings) alter-
native to centre-based programmes for patients not want-
ing to engage in group-based rehabilitation and is a
solution to overcome other barriers including travel
constraints.
Patients with heart failure often experience a decline in
health-related quality of life. Following clinical presentation/
Table 2 Cardio-metabolic changes (mean ± SD) following 12 weeks of Active-at-Home-HF intervention
Pre-intervention Post-intervention P value % change
Measurements at rest
Oxygen consumption (ml/kg/min) 3.8 ± 1.0 4.1 ± 0.8 0.36 7.9
Respiratory exchange ratio 0.85 ± 0.1 0.85 ± 0.1 0.92 0
Heart rate (beats/min) 67 ± 7 70 ± 7 0.24 4.5
Stroke volume index (ml/beat) 48 ± 9 49 ± 8 0.75 2.0
Cardiac output (l/min) 6.1 ± 1 6.6 ± 1 0.14 8.2
Systolic blood pressure (mmHg) 118 ± 18 124 ± 18 0.41 4.0
Diastolic blood pressure (mmHg) 74 ± 8 76 ± 12 0.74 2.6
Mean arterial pressure (mmHg) 90 ± 9 92 ± 13 0.66 2.2
Measurements at peak exercise
Oxygen consumption (ml/kg/min) 16.8 ± 3.8 17.6 ± 4.2 0.54 4.8
Respiratory exchange ratio 1.05 ± 0.1 1.07 ± 0.1 0.62 1.9
Heart rate (beats/min) 106 ± 19 107 ± 16 0.92 1.0
Stroke volume (ml/beat) 127 ± 34 151 ± 34 0.05 18.9
Stroke volume index (ml/beat/m2) 64 ± 14 75 ± 17 0.04 17.2
Cardiac output (l/min) 13.4 ± 4 15.3 ± 4.9 0.19 14.2
Cardiac index (l/min/m2) 6.8 ± 1.5 7.6 ± 2.0 0.19 11.7
Systolic blood pressure (mmHg) 155 ± 30 150 ± 30 0.62 3.2
Diastolic blood pressure (mmHg) 80 ± 8 79 ± 8 0.72 1.3
Mean arterial pressure (mmHg) 103 ± 13 102 ± 13 0.87 1.0
Peak exercise workload (watts) 82 ± 10 91 ± 19 0.21 11
Exercise workload at anaerobic threshold (watts) 49 ± 16 59 ± 14 0.01 20
Oxygen consumption at anaerobic threshold (ml/kg/min) 11.5 ± 2.9 12.8 ± 2.2 0.39 11.3
Rate of perceived exertion 16 ± 2.4 17 ± 2.3 0.22 6.3
Table 3 Blood biomarkers and quality of life (mean ± SD) following 12 weeks of Active-at-Home-HF
Pre-intervention Post-intervention P value % change
Cholesterol (mmol/l) 4.0 ± 0.9 3.9 ± 0.9 0.59 2.5
Triglyceride (mmol/l) 1.5 ± 0.7 1.8 ± 0.9 0.45 20
HDL (mmol/l) 1.2 ± 0.3 1.1 ± 0.3 0.67 8.3
LDL (mmol/l) 2.1 ± 0.7 1.9 ± 0.7 0.46 9.5
HbA1c (mmol/mol) 49.2 ± 17.3 47.5 ± 12 0.77 3.5
FBG (mmol/l) 6.2 ± 2.9 7.0 ± 3.8 0.56 12.9
NT proBNP (pg/ml) 823 ± 1085 876 ± 1114 0.89 6.4
Renal function eGFR 65.4 ± 18.6 61.4 ± 17.4 0.61 6.1
QoL 26 ± 18 22 ± 23 0.50 15.4
HDL high-density lipoprotein, LDL low-density lipoprotein, HBA1c glycated haemoglobin, FBG fasting blood glucose, NT proBNP N-terminal brain natriuretic
peptide, QoL quality of life, eGFR glomerular filtration rate
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diagnosis, psychological distress can limit activity and lead
to a decline in quality of life [21]. Exercise training has been
reported to improve quality of life in CHF [22], and a reduc-
tion of 5 points or more in the Minnesota living with heart
failure questionnaire is accepted as being clinically signifi-
cant [23]. The present pilot feasibility study reported a 15%
(4 point) reduction in quality of life score (i.e. an improve-
ment in quality of life) which is deemed clinically insignifi-
cant and as thus contrast studies that have reported a
significant improvement in quality of life following exercise
intervention [24]. However, a 15% improvement is positive
in a group of participants who reported a higher than aver-
age quality of life score at baseline (i.e. mean values of 26
points out of a possible score of 105 points in the question-
naire). Cowie et al. [25] also reported no significant change
in quality of life in CHF patients following home-based or
hospital-based intervention, even though there was a signifi-
cant improvement in exercise capacity. They further sug-
gested that in older CHF patients, maintaining quality of life
rather than improving it might be a realistic aim for a phys-
ical activity or rehabilitation programme.
At anaerobic threshold, participants were able to
tolerate significantly greater workload (17% increase).
This finding is similar to previous studies that also
reported a delay in reaching anaerobic threshold [26]
and a significant increase in power output at anaer-
obic threshold [27].
Similarly, increased daily physical activity resulted in a
19% significant increase in peak stroke volume. Our re-
sults suggest positive adaptation to the intervention and
the improvement of systemic oxygen delivery. Other
studies have also reported significant improvements in
an echocardiogram-generated stroke volume as a result
of long-term (> 12 weeks) exercise training [28]. The
capacity to increase physical activity depends on the
ability of the heart to generate adequate cardiac output
and the ability of skeletal muscles to utilise the oxygen
delivered [29]. Therefore, this provides strong evidence
for the assessment of cardiac heamodynamics in re-
sponse to a physical activity intervention. These findings
have been extended by other studies which demon-
strated that aerobic training also improves diastolic fill-
ing, myocardial contractility and left ventricular ejection
fraction in individuals with severe left ventricular systolic
dysfunction [30, 31]. Based on the findings of the
current study and evidence from the above-mentioned
studies, it is reasonable to suggest that physical activity
in CHF can improve cardiac contractility and stroke vol-
ume, potentially leading to reverse remodelling. The
present study also found that increased physical activity
as recorded from step counts following the Active-at-
Home-HF intervention had a stronger correlation with
peak oxygen consumption compared with lower step
counts (sedentary behaviour) pre-intervention. Jehn
et al., who reported a positive correlation between the
times spent in light activity/exercise (≤ 3 METs) and im-
proved peak oxygen consumption [11], had demon-
strated this previously.
Although the use of steps per day has been criticised
for not taking into account exercise intensity [32], a re-
cent study by Tudor-Locke et al. [33] has shown that
linear trends for steps per day were statistically signifi-
cant for cardio-metabolic risk factors including blood
pressure for men, weight, waist circumference, insulin,
high-density lipoprotein, triglycerides and homeostasis
model assessment-estimated insulin resistance. Even at
step counts of around 70 steps per minute, which is
below the recommended 100 steps per minute suggest-
ing moderate intensity [32], clinically favourable values
for many of the cardio-metabolic outcomes were
Fig. 3 Relationship between number of steps and peak oxygen consumption pre- and post-intervention
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observed. The present study provides further justifica-
tion for the use of steps per day recommendations in na-
tional physical activity guidelines [34]. Furthermore, the
present study results are of clinical importance for the
management of CHF patients, particularly older adults
as most patients have concomitant exercise-limiting co-
morbidities such as neuromuscular or orthopaedic prob-
lems making the traditional 10,000 step target [35] or
steps per minute unrealistic and potentially harmful. As
such, it may be appropriate to encourage such patients
to exercise at a lower intensity than has been considered
necessary to increase maximal exercise capacity.
Limitations
The following limitations should be considered in the
present study. Firstly, it could be argued that sample size
limits generalisability of findings. Of the 43 patients
screened, only 20 were enrolled into the study meaning
a recruitment rate of 46%. However, this was a pilot
study with the primary aim of establishing acceptability
and feasibility of the intervention. A further criticism
could be that this study lacked a control group. How-
ever, the primary intention of this study was not to es-
tablish the effect of the intervention, instead, it was to
assess feasibility and acceptability with a view to inform-
ing a larger-scale evaluation (i.e. controlled trial) should
the intervention prove to be feasible and acceptable. Sec-
ondly, it could be argued that stroke volume was mea-
sured non-invasively which is not the gold standard.
However, the reproducibility of stroke volume measure-
ments using the NICOM has previously been reported
[36]. Lastly, only two female patients were recruited into
the study limiting generalisability of the study findings
in terms of gender. The nature of this pilot study did
not necessitate the use of digital technologies. However,
digital technologies which offer additional evaluation of
haemodynamic function such as heart rate and blood
pressure will be useful in future studies to improve
safety of patients while engaging in physical activity, and
would likely increase feasibility. Further evaluation of
the ACTIVE-at-HOME intervention, clinical and cost-
effectiveness is warranted in an adequately powered ran-
domised controlled trial
Conclusion
The present study demonstrates that the novel, home-
based physical activity intervention (i.e. Active-at-Home-
HF) is acceptable and feasible and can provide clinical
and physiological benefits to people living with CHF.
The intervention is associated with increased habitual
physical activity level, functional capacity and haemo-
dynamic response to exercise. Significant changes in re-
sponse to the Active-at-Home-HF intervention were
observed in submaximal exercise capacity and cardiac
response to exercise. The Active-at-Home-HF interven-
tion provides a viable alternative to centre-based pro-
grammes. This helps to overcome barriers including
travel cost and reluctance to participate in group-based
activity. A larger multicentre study is warranted to fur-
ther substantiate preliminary findings from the present
study.
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